Literature DB >> 11174130

Genetic susceptibility and severity of alopecia areata in human and animal models.

K McElwee1, P Freyschmidt-Paul, A Ziegler, R Happle, R Hoffmann.   

Abstract

Alopecia areata (AA) is a non-scarring, inflammatory form of hair loss. Human and animal model observations suggest that AA is an autoimmune mediated disease. Genetic influence has been clearly demonstrated in many other autoimmune diseases and one would expect that AA is no exception. AA in rodent models involves genetic susceptibility and it is possible to cross breed the AA phenotype to unrelated rodent strains. Segregation analysis of rodent breeding programs suggests the involvement of several dominant and secondary genes. The increased frequency of AA in genetically related individuals, suggests that human AA expression also involves genetic susceptibility. Within the general population, AA does not segregate as a Mendelian, monogenic trait. AA is a continuous trait with varying degrees of hair loss within the affected population. This suggests that human AA expression involves a complex interaction of multiple genes. AA is most likely a polygenic disease where several, potentially identifiable, major genes affect disease susceptibility and minor severity modifying genes may further affect the phenotype. Here we review the literature on humans and animal models for AA to identify data in support of AA as a polygenic, multivariate penetrance disease with a threshold level for disease onset. Genome wide allelic association screening of animal models and genetically related human sibling pairs may be a suitable approach to identifying susceptibility and severity modifying genes for AA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11174130

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  5 in total

Review 1.  [Alopecia areata. Clinical aspects, pathogenesis and rational therapy of a T-cell-induced autoimmune disease].

Authors:  P Freyschmidt-Paul; R Happle; R Hoffmann
Journal:  Hautarzt       Date:  2003-08       Impact factor: 0.751

2.  Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model.

Authors:  Xingqi Zhang; Mei Yu; Wayne Yu; Joanne Weinberg; Jerry Shapiro; Kevin J McElwee
Journal:  J Invest Dermatol       Date:  2008-11-20       Impact factor: 8.551

Review 3.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

4.  Fibroblast cell-based therapy prevents induction of alopecia areata in an experimental model.

Authors:  Reza B Jalili; Ruhangiz T Kilani; Yunyuan Li; Mohsen Khosravi-Maharlooie; Layla Nabai; Eddy Hsi Chun Wang; Kevin J McElwee; Aziz Ghahary
Journal:  Cell Transplant       Date:  2018-06-05       Impact factor: 4.064

5.  Monotherapy for Alopecia Areata: A Systematic Review and Network Meta-Analysis.

Authors:  Aditya K Gupta; Jessie L Carviel; Kelly A Foley; Neil H Shear; Bianca Maria Piraccini; Vincent Piguet; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2019-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.